We have shown an association between the use of biguanides and liraglutide and a reduced risk of composite endpoint in DM patients (International Journal of Cardiology)
Diabetes News Service
Glycosmedia is also available as an App:
For iPhone and iPad | For Android devices
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
